SC: Appeal U/S 374 CrPC/415 BNSS is Not Maintainable Against Sessions Court's Reversal of Acquittal || SC Asked the Centre to Promote Awareness About the Consequences of Driving With an Expired Licence || SC Explains How a Deceased Christian Wife's Property Devolves under the Indian Succession Act || Supreme Court: Reach Stacker isn't a Motor Vehicle; MACT Claim Not Maintainable || Supreme Court: Lift Makers, Operators and Owners Share Responsibility for User Safety || Patna HC: Pressure to Sign Divorce and Child Custody does not Amount to Cruelty || Bombay HC: Externment under the Police Act Requires Satisfaction About a Gang's Activities || Bombay HC: False Travel Distance Claim Alone Doesn't Constitute Misappropriation || J&K&L High Court: Interest on Delayed Gratuity is Not a Mandatory Pre-Deposit For an Appeal || Meghalaya HC: Meritorious Candidate Cannot Be Denied Admission For a Two-Minute Delay

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :